conveni
effici
synthesi
novel
class
acycl
nucleosid
phosphon
deriv
phosphonomethoxi
propano
acid
develop
key
step
synthesi
optim
oxid
phosphonomethoxi
propyl
hpmp
analogu
correspond
cpme
deriv
use
temponaclo
naclo
oxid
system
although
phosphonomethoxi
propano
acid
cpmea
design
compound
potenti
antihiv
activ
none
newli
prepar
cpme
analogu
exhibit
antivir
activ
acycl
nucleosid
phosphon
anp
constitut
distinguish
class
antivir
agent
also
exhibit
import
cytostat
antiparasit
immunomodulatori
activ
main
advantag
anp
resist
toward
degrad
enzym
vivo
abil
bypass
first
phosphoryl
step
necessari
activ
bioactiv
nucleosid
three
anp
approv
worldwid
clinic
use
hpmpc
cidofovir
vistid
treatment
cmv
retin
aid
patient
pmea
fig
oral
prodrug
adefovir
dipivoxil
hepsera
treatment
chronic
hbv
infect
pmpa
fig
oral
prodrug
tenofovir
disoproxil
fumar
viread
treatment
hiv
combin
antivir
chronic
hbv
infect
mani
anp
found
exhibit
import
antivir
properti
eg
deriv
hpmpdap
pmedap
pmpdap
open
ring
deriv
hpmpoedapi
pmeoedapi
pmpoedapi
like
nucleotid
due
poor
bioavail
anp
administ
form
prodrug
inject
case
cidofovir
analogu
contain
adenin
play
special
role
among
anp
potent
antivir
properti
hpmpa
fig
prototyp
anp
deriv
dhpa
possess
broadspectrum
activ
dna
virus
includ
herp
adeno
poxand
iridovirus
well
retrovirus
hpmp
enantiom
activ
adenin
seri
ophosphonomethyl
regioisom
isohpmpa
exhibit
antivir
activ
approv
adenin
analogu
pmea
pmpa
primarili
activ
hepadnaand
retrovirus
pmea
also
exhibit
notabl
activ
herpesvirus
final
fpmpa
prove
less
antivir
effect
also
less
toxic
pmea
thoroughli
studi
antiretrovir
activ
pursu
clinic
use
number
adenin
deriv
prove
import
antivir
activ
acycl
nucleosid
analogu
like
dhpa
fig
market
czechoslovakia
duvira
gel
structur
relat
deritadenin
acid
ahpa
constitut
anoth
class
broadspectrum
antivir
acycl
analogu
adenosin
target
sadenosyllhomocystein
hydrolas
thu
cap
process
methyl
endguanin
viral
mrna
herein
describ
synthesi
biolog
properti
novel
type
acycl
nucleosid
phosphon
structur
relat
abovement
biolog
import
compound
novel
type
anp
deriv
phosphonomethoxi
propano
acid
adenin
deriv
carboxypmea
cpmea
fig
promis
candid
potenti
biolog
properti
xray
structur
rtedna
complex
incorpor
tenofovir
diphosph
ideal
start
point
ration
target
drug
design
fig
complex
two
amino
acid
residu
arg
gln
bind
site
rt
orient
toward
methyl
group
tenofovir
diphosph
fig
appar
incap
methyl
group
substanti
interact
two
polar
amino
acid
rt
led
us
reason
replac
methyl
polar
group
abl
interact
arg
andor
gln
would
increas
bind
affin
inhibitor
rt
dock
studi
indic
replac
methyl
group
tenofovir
diphosph
fig
carboxyl
group
could
theoret
lead
format
upto
four
new
hydrogen
bond
arginin
glutamin
fig
initi
dock
studi
indic
cpmea
fig
analogu
pmea
bear
carboxyl
group
posit
aliphat
chain
potenti
good
candid
strong
bind
affin
enzym
pocket
rt
moreov
cpmea
consid
direct
structur
modif
pmpa
hpmpa
oxid
methyl
function
respect
also
look
upon
ophosphonomethyl
deriv
ahpa
fig
thu
compound
well
cpme
analogu
expect
display
wide
rang
biolog
properti
gener
two
strategi
could
util
synthesi
target
analogu
cpmea
fig
direct
oxid
properli
protect
hpmpa
follow
remov
protect
group
b
alkyl
adenin
suitabl
alkyl
agent
contain
protect
carboxyl
function
follow
deprotect
ammonolysi
case
oxid
protect
hpmpa
deriv
seem
relev
straightforward
method
synthesi
compound
synthon
approach
seem
labori
less
effect
thu
diisopropyl
phosphonomethoxi
propyl
adenin
scheme
chosen
suitabl
start
materi
prepar
suffici
amount
accord
previous
describ
procedur
nowaday
consider
number
oxid
agent
use
rel
mild
reaction
condit
toler
number
function
group
goal
develop
simpl
mild
clean
oxid
hpmpa
deriv
would
toler
presenc
unprotect
amino
group
posit
purin
moieti
convers
hydroxyl
group
protect
purin
nucleosid
correspond
uron
acid
often
accomplish
oxid
excess
kmno
aqueou
koh
solut
condit
high
dilut
attempt
oxid
compound
analog
reaction
condit
led
complex
reaction
mixtur
tlc
simpl
effici
oxid
convers
primari
alcohol
correspond
methyl
ester
use
k
co
meoh
report
mori
togo
nevertheless
attempt
prepar
methyl
ester
deriv
direct
oxid
esterif
compound
report
reaction
condit
success
tabl
ruthenium
tetroxid
ruo
anoth
wide
use
oxid
agent
ideal
vigor
oxid
agent
need
mild
reaction
condit
must
maintain
sinc
ruo
decompos
explos
mostli
prepar
situ
oxid
rucl
ruo
mild
oxid
nucleosid
correspond
carboxyl
acid
use
rucl
naio
rucl
k
koh
system
report
sinc
rucl
found
hygroscop
reagent
easi
handl
ruo
oxid
agent
choic
oxid
diisopropyl
hpmpa
ruo
naio
afford
deriv
satisfactori
yield
tabl
oxid
carri
mixtur
acetonitril
chloroform
water
accord
describ
procedur
use
prepar
adenosin
uronamid
addit
concentr
hcl
ph
despit
good
isol
yield
purif
tediou
column
chromatographi
repeat
sever
time
obtain
pure
cpmea
deriv
probabl
owe
fact
phosphon
strongli
bind
metal
ion
thu
cleaner
less
labori
procedur
still
desir
commerci
avail
tempo
reagent
choic
oxid
variou
organ
substrat
tempo
belong
class
stabl
organ
nitroxyl
radic
commonli
use
oxid
primari
secondari
alcohol
mild
effici
oxid
alcohol
keton
aldehyd
use
catalyt
amount
tempo
stoichiometr
amount
bi
acetoxi
iodo
benzen
baib
develop
method
differ
tempomedi
oxid
gener
acet
acid
iodobenzen
byproduct
avoid
inorgan
contamin
oxid
system
success
employ
oxid
protect
nucleosid
give
correspond
carboxyl
acid
case
oxid
hpmpa
deriv
tempobaib
oxid
system
afford
expect
product
yield
tabl
even
better
yield
cpmea
deriv
achiev
baib
replac
naclo
naclo
sodium
hypochlorit
readili
avail
inexpens
oxid
household
bleach
oxid
system
temponaclo
naclo
offer
clean
reaction
easi
workup
base
isol
product
flash
chromatographi
silica
gel
follow
crystal
effici
procedur
offer
compound
high
puriti
final
desir
product
cpmea
obtain
yield
ester
cleavag
compound
standard
condit
sibr
mecn
analog
oxid
enantiomer
diisopropyl
r
hpmpa
use
temponaclo
naclo
system
afford
deriv
yield
subsequ
deprotect
compound
gave
free
phosphon
acid
yield
unfortun
none
oxid
system
list
tabl
afford
cpmea
direct
oxid
free
hpmpa
fig
confirm
import
diester
protect
phosphon
group
procedur
synthet
transform
gener
eventu
decid
verifi
gener
applic
optim
oxid
protocol
util
prepar
cpme
deriv
bear
nucleobas
scheme
tabl
thu
expect
diisopropyl
cpme
analogu
obtain
oxid
correspond
hpmp
deriv
temponaclo
naclo
high
yield
function
group
unprotect
nucleobas
usual
well
toler
oxid
process
problem
observ
compound
bear
base
contain
guanidin
motif
guanin
purin
treatment
hpmpg
deriv
hpmpdap
deriv
temponaclo
naclo
gave
complex
colour
reaction
mixtur
desir
product
isol
entri
respect
tabl
overcom
undesir
reactiv
base
decid
protect
amino
group
compound
benzoyl
group
thu
n
benzoylguanin
deriv
prepar
yield
compound
pyridin
sequenti
treatment
sicl
bzcl
water
aqueou
ammonia
scheme
subsequ
oxid
benzoyl
deriv
temponaclo
naclo
afford
carboxi
analogu
yield
tabl
entri
direct
deprotect
phosphon
moieti
compound
use
sibr
acetonitril
afford
n
benzoylguanin
deriv
yield
tabl
entri
scheme
order
obtain
cpmeg
benzoyl
group
deriv
remov
first
use
meona
solut
follow
remov
isopropyl
group
intermedi
scheme
analog
hpmpdap
analogu
protect
dibenzoyl
deriv
yield
effici
oxid
use
temponaclo
naclo
system
compound
yield
tabl
entri
scheme
final
cpmedap
obtain
yield
compound
simultan
hydrolysi
benzoyl
group
diisopropyl
ester
use
scheme
synthesi
cpmea
r
cpmea
oxid
hpmpa
deriv
scheme
synthesi
cpme
compound
start
hpmp
analogu
oxid
hpmp
analogu
temponaclo
naclo
give
follow
diester
remov
yield
entri
nucleobas
b
start
compound
product
yield
oxid
product
yield
phosphon
deprotect
scheme
synthesi
cpmeg
use
temponaclo
naclo
key
step
aqueou
hcl
microwav
irradi
scheme
gener
method
conveni
deprotect
phosphon
diester
recent
develop
laboratori
prepar
diisopropyl
cpme
phosphon
deprotect
final
free
phosphon
acid
tabl
scheme
alreadi
mention
two
gener
method
remov
alkyl
ester
phosphon
group
employ
commonli
use
deprotect
sibr
acetonitril
follow
hydrolysi
method
b
recent
describ
microwaveassist
hydrolysi
use
aqueou
hcl
method
b
method
gave
better
yield
free
phosphon
acid
compar
method
b
diisopropyl
phosphon
methoxi
group
posit
pyrimidin
ring
afford
deprotect
condit
method
b
correspond
thymin
deriv
tabl
entri
newli
prepar
cpme
analogu
test
antivir
properti
although
complet
nontox
assay
none
compound
includ
promis
cpmea
exhibit
promis
activ
viru
virus
test
ko
ko
tk
g
rsv
vaccinia
viru
vesicular
stomat
viru
viru
sindbi
viru
coxsacki
viru
punta
toro
viru
felin
corona
viru
felin
herp
viru
one
obviou
reason
lack
biolog
properti
cpme
deriv
may
poor
bioavail
caus
high
polar
cpme
deriv
even
polar
correspond
pme
pmp
hpmp
analogu
sinc
major
therapeut
success
anp
administ
form
prodrug
prepar
variou
prodrug
lead
cpmea
current
progress
report
elsewher
novel
acycl
nucleosid
analogu
phosphonomethoxi
propano
acid
cpmea
design
inhibitor
rt
synthesi
develop
optim
key
step
cpmea
synthesi
consist
oxid
hpmpa
deriv
temponaclo
naclo
give
compound
high
yield
subsequ
whole
seri
cpme
deriv
prepar
high
yield
correspond
hpmp
analogu
optim
oxid
methodolog
use
tempo
oxid
process
toler
function
group
present
common
nucleobas
c
u
except
compound
contain
amino
group
posit
purin
ring
ie
compound
oxid
benzoyl
deriv
respect
final
two
method
employ
deprotect
phosphon
diester
treatment
sibr
acetonitril
follow
hydrolysi
b
microwaveassist
hydrolysi
aqueou
hcl
unfortun
none
newli
synthes
cpme
compound
includ
promis
cpmea
show
interest
activ
virus
test
analyt
tlc
perform
silica
gel
precoat
aluminium
plate
fluoresc
indic
merck
f
spot
visual
uv
light
nm
spray
solut
ethanol
follow
short
heat
c
spray
concentr
ammonia
solut
water
column
chromatographi
carri
silica
gel
sigma
mm
mass
spectra
measur
qtof
micro
water
hrm
taken
ltq
orbitrap
xl
thermo
fisher
scientif
spectromet
h
c
nmr
spectra
record
bruker
avanc
h
mhz
c
mhz
bruker
avanc
h
mhz
c
mhz
bruker
avanc
h
mhz
c
mhz
dmsod
referenc
solvent
signal
ppm
respect
referenc
dioxan
intern
standard
complet
assign
base
heteronuclear
correl
experi
hsqc
h
chmbc
chemic
shift
part
per
million
coupl
constant
j
hertz
uv
spectra
taken
beckman
spectrophotomet
methanol
water
solut
ir
spectra
obtain
ft
ir
bruker
equinox
if
spectromet
kbr
pellet
microwaveassist
reaction
carri
cem
discov
explor
microwav
apparatu
system
vessel
seal
teflon
septum
oper
frequenc
ghz
continu
irradi
power
w
solut
steadili
stir
reaction
temperatur
measur
ir
sensor
outer
process
vessel
vial
cool
ambient
temperatur
ga
jet
cool
system
pressur
measur
inboard
cem
explor
pressur
control
system
bar
household
bleach
savo
purchas
bochemi
lidick
czech
republ
concentr
sodium
hypochlorit
determin
iodometr
titrat
mgml
start
hpmp
analogu
prepar
accord
publish
procedur
dock
studi
fig
perform
arguslab
program
use
argusdock
algorithm
exhaust
search
perform
enabl
high
precis
option
dock
precis
menu
dock
chosen
calcul
type
flexibl
ligand
space
grid
point
use
atom
coordin
xray
structur
rtedna
complex
incorpor
antihiv
drug
tenofovir
download
protein
data
bank
pdb
code
final
inhibitoreprotein
complex
visual
use
arguslab
start
hpmp
deriv
mmol
dissolv
dri
pyridin
ml
roundbottom
flask
dri
tube
reaction
mixtur
cool
ice
bath
sibr
mmol
ad
reaction
mixtur
min
benzoyl
chlorid
mmol
ad
reaction
flask
remov
ice
bath
mixtur
stir
h
room
temperatur
reaction
mixtur
cool
ice
bath
cold
water
ml
ad
follow
min
stir
concentr
aqueou
ammonia
ml
mixtur
stir
room
temperatur
anoth
min
solvent
remov
vacuo
give
crude
oil
chromatographi
silica
gel
column
methanol
chloroform
afford
product
thick
yellowish
oil
n
phosphonomethoxi
propyl
guanin
yield
yellowish
solid
recryst
etoachexan
mp
c
mp
c
msesi
mz
compound
mmol
mg
ruo
mmol
mg
naio
mmol
g
vigor
stir
mixtur
ch
cn
ml
chcl
ml
h
ml
concentr
hcl
eight
drop
ad
wph
heterogen
mixtur
vigor
stir
room
temperatur
h
solid
remov
filtrat
reaction
mixtur
silica
gel
layer
wash
methanol
solvent
evapor
residu
purifi
column
chromatographi
silica
gel
chcl
meohacoh
purif
repeat
two
time
remov
colour
byproduct
inorgan
salt
desir
product
mg
obtain
yellowish
oil
upon
stand
etoacmeoh
mixtur
crystal
compound
mmol
mg
tempo
mmol
mg
baib
mmol
mg
mixtur
ch
cn
ml
h
ml
stir
room
temperatur
h
solvent
evapor
flash
chromatographi
silica
gel
chcl
meoh
afford
product
mg
yellowish
oil
upon
stand
etoacmeoh
mixtur
crystal
oxid
diisopropyl
hpmp
deriv
temponaclo
naclo
gener
procedur
correspond
hpmp
deriv
mmol
tempo
mmol
mg
naclo
mmol
mg
mixtur
ch
cn
ml
aqueou
sodium
phosphat
buffer
ml
wph
vigor
stir
room
temperatur
aqueou
solut
sodium
hypochlorit
mgml
prepar
dilut
household
bleach
savo
ml
h
ml
ad
mixtur
stir
room
temperatur
reaction
complet
h
solvent
evapor
flash
chromatographi
silica
gel
column
chcl
meoh
afford
desir
cpme
product
good
yield
yellowish
oil
upon
stand
etoacmeoh
mixtur
gave
yellowish
crystal
